FDA launches “Operation Stork Speed” to strengthen infant formula oversight

USA – The US Food and Drug Administration (FDA) has introduced “Operation Stork Speed,” a new initiative aimed at improving the safety and reliability of infant formula across the country.

Reported by the FDA, this program seeks to strengthen oversight of the infant-formula industry, ensuring that products meet high standards for quality, safety, and nutrition while building a more resilient supply chain.

The initiative is part of a broader effort announced by the FDA in January to enhance its monitoring of infant formula production. 

According to agency officials, Operation Stork Speed will focus on maintaining the nutritional adequacy of these products and addressing vulnerabilities exposed during past crises. 

The move follows the February 2022 infant formula shortage, sparked by contamination concerns at Abbott’s facility in Sturgis, Michigan. 

A report by the FDA highlighted how Cronobacter sakazakii contamination led to a massive recall, plant closure, and emergency imports, pushing the agency to rethink its approach to regulation.

US Department of Health and Human Services Secretary Robert F. Kennedy, Jr. said, “The FDA will use all resources and authorities at its disposal to make sure infant-formula products are safe and wholesome for the families and children who rely on them.” 

The agency is now rolling out several key actions, including a nutrient review process and expanded testing for heavy metals and contaminants. 

It is also pressing companies to improve transparency and update labeling practices to provide clearer information for parents and caregivers.

FDA acting commissioner Sara Brenner emphasized the agency’s dedication to the cause. 

“The FDA is deeply committed to ensuring that moms and other caregivers of infants and young children and other individuals who rely on infant formula for their nutritional needs have confidence that these products are safe, consistently available, and contain the nutrients essential to promote health and well-being during critical stages of development and life,” she said. 

In the coming months, the FDA plans to launch its first comprehensive review of infant formula nutrients since 1998, a significant step toward modernizing standards.

Beyond regulatory changes, the FDA is working with the National Institutes of Health and other scientific groups to study the long-term health effects of formula feeding. 

The agency is also encouraging innovation by supporting the development of new infant formulas. 

A report by the FDA noted its collaboration with other government bodies, stressing that fixing the infant-formula market’s weaknesses requires a team effort. 

With Operation Stork Speed, the FDA aims to restore public trust and ensure a stable supply of safe, nutritious formula for American families.